SFATA reports that The National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health, is seeking proposals from small businesses to develop a standardized electronic cigarette for use in clinical studies. The goal is to evaluate the harm reduction benefits/risks of e-cigarettes, as well as their potential as smoking cessation aids.
The release in a recent SFATA newsletter says that there is insufficient data to assess the overall impact of e-cigarettes on public health or to fully inform public policy. E-cigarettes on the market today do not have the product and manufacturing documentation the FDA usually requires to allow clinical trials to proceed. To accelerate e-cigarette research, NIDA is therefore seeking to develop a well characterized product for use in clinical research.
This opportunity is only open to businesses with fewer than 500 employees.
The full solicitation can be found using a search engine with the keywords “SBIR Topic 156b” or by going to: